NITRO: A Randomised Phase 3 Trial Of Adding Nitroglycerin To First Line Chemotherapy For Advanced Non-small Cell Lung Cancer
Funder
National Health and Medical Research Council
Funding Amount
$504,960.00
Summary
Preliminary studies suggest that nitroglycerin paste can substantially improve the results of chemotherapy for advanced lung cancer. NITRO is a definitive, large-scale, randomised trial that is needed to reliably determine if these promising results are true, and worthy of widespread application in routine clinical practice.